BioLife Solutions, Inc.
US ˙ NasdaqCM ˙ US09062W2044

SecurityBLFS / BioLife Solutions, Inc.
InstitutionRoyce Value Trust Inc
Latest Disclosed Ownership52,669 shares
Latest Disclosed Value $ 1,134,490
Royce Value Trust Inc reports 68.11% decrease in ownership of BLFS / BioLife Solutions, Inc.

On August 15, 2025 - Royce Value Trust Inc filed a NPORT-P form disclosing ownership of 52,669 shares of BioLife Solutions, Inc. (US:BLFS) valued at $1,134,490 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 19, 2025 disclosing 165,181 shares of BioLife Solutions, Inc.. This represents a change in shares of -68.11% during the quarter. The current value of the position is $1,403,629 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-15 2025-06-30 NP BioLife Solutions EC US09062W2044 52,669 -112,512 -68.11 1,134 -69.94 0.0566
2025-05-19 2025-03-31 NP BioLife Solutions EC US09062W2044 165,181 41,043 33.06 3,773 17.07 0.2050
2025-02-21 2024-12-31 NP BioLife Solutions EC US09062W2044 124,138 -18,114 -12.73 3,223 -9.52 0.1613
2024-11-19 2024-09-30 NP BioLife Solutions EC US09062W2044 142,252 -35,369 -19.91 3,562 -6.44 0.1763
2024-08-12 2024-06-30 NP BioLife Solutions EC US09062W2044 177,621 132,732 295.69 3,806 357.45 0.1995
2024-05-28 2024-03-31 NP BioLife Solutions EC US09062W2044 44,889 -195,411 -81.32 833 -78.69 0.0426
2024-02-20 2023-12-31 NP BioLife Solutions EC US09062W2044 240,300 154,354 179.59 3,905 229.17 0.2095
2023-11-22 2023-09-30 NP BioLife Solutions EC US09062W2044 85,946 70,746 465.43 1,187 109.54 0.0714
2022-02-24 2021-12-31 NP BioLife Solutions EC US09062W2044 15,200 7,160 89.05 567 66.47 0.0263
2021-11-22 2021-09-30 NP BioLife Solutions EC US09062W2044 8,040 1,960 32.24 340 25.93 0.0163
2021-08-24 2021-06-30 NP BioLife Solutions EC US09062W2044 6,080 -81,720 -93.08 271 -91.46 0.0125
2021-05-17 2021-03-31 NP BioLife Solutions EC US09062W2044 87,800 -336,500 -79.31 3,161 -81.33 0.1513
2021-02-19 2020-12-31 NP BioLife Solutions EC US09062W2044 424,300 0 0.00 16,925 37.84 0.8962
2020-11-24 2020-09-30 NP BioLife Solutions EC US09062W2044 424,300 126,800 42.62 12,279 152.45 0.8128
2020-08-19 2020-06-30 NP BioLife Solutions EC US09062W2044 297,500 95,500 47.28 4,864 153.47 0.3377
2020-05-27 2020-03-31 NP BioLife Solutions EC US09062W2044 202,000 202,000 1,919 0.1714
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.